ITClinic ApS: Financial statements 2023
CVR: 37811696
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ITClinic ApS (CVR 37811696) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 234,561 and a net result of DKK 112,848 compared with DKK 135,464 the year before. That is an increase of 16.8% compared with the year before. Equity in the 2023 report amounted to DKK 311,029. The solvency ratio was 72.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 234,561
- Profit/Loss
- DKK 112,848
- Equity
- DKK 311,029
- Total Assets
- DKK 429,677
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 235 t. | 113 t. | 311 t. | 1 |
| 2022 | - | 201 t. | 135 t. | 320 t. | - |
| 2021 | - | 387 t. | 177 t. | 290 t. | - |
| 2020 | - | 162 t. | -47 t. | 163 t. | - |
| 2019 | - | 225 t. | 143 t. | 422 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ITClinic ApS has published its annual report for 2022. Gross profit came to DKK 200,851, and the net result was DKK 135,464.
About ITClinic ApS
ITClinic ApS is a Danish company of the type Anpartsselskab based in Sønderborg, founded in 2016. The company is registered under the industry Detailhandel med sports- og fritidsudstyr. The management consists of Parviz Vosooghi Narmighi. The company is owned by Parviz Vosooghi Narmighi. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 176,551 and a net result of DKK 86,038 compared with DKK 74,114 the year before. Equity in the 2025 report amounted to DKK 214,181.